US Patent 9840519 Macrocyclic compounds as TRK kinase inhibitors
Patent 9840519 was granted and assigned to Array Biopharma Inc. on December, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 14, 2016
0
Date of Patent
December 12, 2017
0
Patent Applicant
Patent Application Number
15350888
0
Patent Inventor Names
Gabrielle R. Kolakowski
0
Qian Zhao
0
Steven W. Andrews
0
Yutong Jiang
0
Hong-Woon Yang
0
Jeongbeob Seo
0
Julia Haas
0
Kevin Ronald Condroski
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9840519 Macrocyclic compounds as TRK kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
